Found: 4
Select item for more details and to access through your institution.
Opioid Prescribing and Outcomes in Patients With Sickle Cell Disease Post–2016 CDC Guideline.
- Published in:
- JAMA Internal Medicine, 2024, v. 184, n. 5, p. 510, doi. 10.1001/jamainternmed.2023.8538
- By:
- Publication type:
- Article
Impact of adherence to hydroxyurea on health outcomes among patients with sickle cell disease.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 1, p. 90, doi. 10.1002/ajh.26765
- By:
- Publication type:
- Article
Single and Combination Drug Therapy for Fetal Hemoglobin Augmentation in Hemoglobin E-β<sup>o</sup>-Thalassemia: Considerations for Treatment.
- Published in:
- Annals of the New York Academy of Sciences, 2005, v. 1054, n. 1, p. 250, doi. 10.1196/annals.1345.031
- By:
- Publication type:
- Article
Fetal haemoglobin augmentation in E/ β<sup>0</sup> thalassaemia: clinical and haematological outcome.
- Published in:
- British Journal of Haematology, 2005, v. 131, n. 3, p. 378, doi. 10.1111/j.1365-2141.2005.05768.x
- By:
- Publication type:
- Article